DIANE ALANE SEMER, MD

GREENVILLE, NC

Research Active
Obstetrics & Gynecology - Gynecologic Oncology NPI registered 21+ years 4 publications 1991 – 2012 NPI: 1245234004
Ovarian NeoplasmsCells, CulturedPrognosisCytokinesNeoplasm StagingEndometrial NeoplasmsOvaryCarcinoma, PapillaryDose-Response Relationship, DrugSurvival AnalysisNorth CarolinaCystadenocarcinomaCystadenoma, SerousFallopian Tube NeoplasmsPeritoneum

Practice Location

1850 W ARLINGTON BLVD
GREENVILLE, NC 27834-5704

Phone: (252) 752-6101

What does DIANE SEMER research?

Dr. Semer studies uterine health, especially the behaviors of papillary serous carcinoma, a serious type of uterine cancer. She investigates how this cancer responds to various treatments and the factors that influence outcomes for patients diagnosed at different stages of the disease. Moreover, she explores the role of cytokines, which are signaling molecules that help regulate immune responses and cell interactions, particularly in relation to human endometrial stromal cells, which play a critical part in the reproductive process. Her research helps enhance knowledge on how these cells behave during pregnancy and how they might react in different conditions.

Key findings

  • In her study on papillary serous carcinoma, 32% of 22 patients developed distant metastases after treatment, with all such cases occurring in patients diagnosed at advanced stages.
  • No patients with early-stage papillary serous carcinoma died from cancer progression, indicating that early detection significantly improves outcomes.
  • Dr. Semer's research on endometrial stromal cells revealed that treatment with the cytokine IL-1 increased the production of IL-1 beta, showcasing the cellular interactions critical to reproductive health.

Frequently asked questions

Does Dr. Semer study uterine cancer?
Yes, Dr. Semer specializes in papillary serous carcinoma, a type of uterine cancer, and her research focuses on its prognosis and treatment outcomes.
What treatments has Dr. Semer researched?
Dr. Semer has researched the outcomes of surgical staging and treatment methods for patients with advanced-stage papillary serous carcinoma.
Is Dr. Semer's work relevant to pregnancy health?
Yes, her studies on endometrial stromal cells and their response to cytokines are important for understanding reproductive health and the cellular functions during pregnancy.

Publications in plain English

Endometrial cancer diagnosed by Sister Mary Joseph nodule biopsy: Case report.

2012

Gynecologic oncology case reports

Nolan C, Semer D

PubMed

Florid cystic endosalpingiosis with extensive peritoneal involvement and concurrent bilateral ovarian serous cystadenoma.

2011

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Patonay B, Semer D, Hong H

PubMed

Prognosis for papillary serous carcinoma of the endometrium after surgical staging.

2001

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Nguyen NP, Sallah S, Karlsson U, Vos P, Ludin A +5 more

Plain English
This study looked at how well patients with a specific type of uterine cancer, called papillary serous carcinoma, fared after different treatments. Among 22 patients reviewed, 32% developed distant metastases, meaning the cancer spread to other parts of the body, and notably, all patients who experienced this had advanced-stage disease when they were first diagnosed. Importantly, no patients with early-stage disease died from cancer progression, highlighting that early detection and staging critically influence outcomes. Who this helps: This benefits patients with uterine papillary serous carcinoma and their doctors by informing treatment decisions based on disease stage.

PubMed

Responsiveness of human endometrial stromal cells to cytokines.

1991

Annals of the New York Academy of Sciences

Semer D, Reisler K, MacDonald PC, Casey ML

Plain English
This study looked at how certain signals, called cytokines, affect human endometrial stromal cells, which are important during pregnancy. The researchers found that when these cells were treated with a cytokine called IL-1, they produced more IL-1 and IL-6, with IL-6 being released into the surrounding environment. Specifically, IL-1 increased IL-1 beta production in a dose-dependent way, but this was not released from the cells as expected. This matters because understanding these interactions can help explain how the endometrial cells communicate with each other and respond to challenges during pregnancy. Who this helps: This helps patients and healthcare providers involved in pregnancy and reproductive health.

PubMed

Frequent Co-Authors

Christy Nolan B Patonay H Hong N P Nguyen S Sallah U Karlsson P Vos A Ludin D Tait M Salehpour

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.